Is Healthy Life overvalued or undervalued?

As of 24 October 2025, the valuation grade for Healthy Life has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 27.10, an EV to EBITDA of 18.01, and a ROCE of 13.87%.
In comparison to its peers, Healthy Life's valuation metrics stand out; for instance, Hindustan Unilever has a PE ratio of 55.92 and an EV to EBITDA of 34.86, while Nestle India shows a PE of 82.53 and an EV to EBITDA of 50.74. Despite a challenging recent performance, with a year-to-date return of -65.73% compared to the Sensex's 7.77%, Healthy Life's valuation suggests it may present a compelling investment opportunity relative to its high-flying peers in the FMCG sector.